Non-Hodgkin lymphoma Bone Marrow Transplant cost in India
| Non-Hodgkin lymphoma Bone Marrow Transplant cost in India | Specific Disease | Autologous BMT Cost (USD) | Allogenic Half Match BMT Cost (USD) | Allogenic Full Match BMT Cost (USD) | Umbilical Cord Blood Transplant BMT Cost (USD) |
| Non-Hodgkin lymphoma (NHL) | NHL – ALK+ large B-cell lymphoma |
$18,180 | $42,420 | $28,280 | $11,110 |
| Non-Hodgkin lymphoma (NHL) | NHL – Adult T-cell lymphoma/leukemia |
$18,253 | $42,590 | $28,393 | $11,154 |
| Non-Hodgkin lymphoma (NHL) | NHL – Aggressive NK-cell leukemia |
$18,326 | $42,760 | $28,507 | $11,199 |
| Non-Hodgkin lymphoma (NHL) | NHL – Anaplastic large-cell lymphoma (ALCL), ALK negative |
$18,399 | $42,931 | $28,621 | $11,244 |
| Non-Hodgkin lymphoma (NHL) | NHL – Anaplastic large-cell lymphoma (ALCL), ALK positive |
$18,473 | $43,103 | $28,735 | $11,289 |
| Non-Hodgkin lymphoma (NHL) | NHL – Angioimmunoblastic T-cell lymphoma |
$18,547 | $43,275 | $28,850 | $11,334 |
| Non-Hodgkin lymphoma (NHL) | NHL – Breast implant-associated anaplastic large-cell lymphoma |
$18,621 | $43,448 | $28,966 | $11,379 |
| Non-Hodgkin lymphoma (NHL) | NHL – Burkitt lymphoma | $18,695 | $43,622 | $29,081 | $11,425 |
| Non-Hodgkin lymphoma (NHL) | NHL – Chronic lymphoproliferative disorder of NK cells |
$18,770 | $43,797 | $29,198 | $11,471 |
| Non-Hodgkin lymphoma (NHL) | NHL – DLBCL associated with chronic inflammation |
$18,845 | $43,972 | $29,315 | $11,516 |
| Non-Hodgkin lymphoma (NHL) | NHL – Diffuse, large B-cell lymphoma (cell of origin unknown) |
$18,920 | $44,148 | $29,432 | $11,562 |
| Non-Hodgkin lymphoma (NHL) | NHL – Diffuse, large B-cell lymphoma- Activated B-cell type (non-GCB) |
$18,996 | $44,324 | $29,550 | $11,609 |
| Non-Hodgkin lymphoma (NHL) | NHL – Diffuse, large B-cell lymphoma- Germinal center B-cell type |
$19,072 | $44,502 | $29,668 | $11,655 |
| Non-Hodgkin lymphoma (NHL) | NHL – EBV+ DLBCL, NOS | $19,148 | $44,680 | $29,786 | $11,702 |
| Non-Hodgkin lymphoma (NHL) | NHL – EBV+ mucocutaneous ulcer |
$19,225 | $44,858 | $29,906 | $11,749 |
| Non-Hodgkin lymphoma (NHL) | NHL – Enteropathy-type T-cell lymphoma |
$19,302 | $45,038 | $30,025 | $11,796 |
| Non-Hodgkin lymphoma (NHL) | NHL – Extranodal NK / T-cell lymphoma, nasal type |
$19,379 | $45,218 | $30,145 | $11,843 |
| Non-Hodgkin lymphoma (NHL) | NHL – Extranodal marginal zone B-cell lymphoma of mucosal associated lymphoid tissue |
$19,457 | $45,399 | $30,266 | $11,890 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular (grade unknown) |
$19,534 | $45,580 | $30,387 | $11,938 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular T-cell lymphoma |
$19,613 | $45,763 | $30,508 | $11,985 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular, mixed, small cleaved and large cell (Grade II follicle center |
$19,691 | $45,946 | $30,630 | $12,033 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular, predominantly large cell (Grade IIIA follicle center lymphoma) |
$19,770 | $46,129 | $30,753 | $12,082 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular, predominantly large cell (Grade IIIA vs IIIB not specified) |
$19,849 | $46,314 | $30,876 | $12,130 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular, predominantly large cell (Grade IIIB follicle center lymphoma) |
$19,928 | $46,499 | $31,000 | $12,178 |
| Non-Hodgkin lymphoma (NHL) | NHL – Follicular, predominantly small cleaved cell (Grade I follicle center lymphoma) |
$20,008 | $46,685 | $31,124 | $12,227 |
| Non-Hodgkin lymphoma (NHL) | NHL – HHV8+ DLBCL, NOS | $20,088 | $46,872 | $31,248 | $12,276 |
| Non-Hodgkin lymphoma (NHL) | NHL – Hepatosplenic T-cell lymphoma |
$20,168 | $47,059 | $31,373 | $12,325 |
| Non-Hodgkin lymphoma (NHL) | NHL – High-grade B-cell lymphoma, NOS |
$20,249 | $47,248 | $31,498 | $12,374 |
| Non-Hodgkin lymphoma (NHL) | NHL – High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements |
$20,330 | $47,437 | $31,624 | $12,424 |
| Non-Hodgkin lymphoma (NHL) | NHL – Indolent T-cell lymphoproliferative disorder of the GI tract |
$20,411 | $47,626 | $31,751 | $12,474 |
| Non-Hodgkin lymphoma (NHL) | NHL – Intravascular large B-cell lymphoma |
$20,493 | $47,817 | $31,878 | $12,523 |
| Non-Hodgkin lymphoma (NHL) | NHL – Large B-cell lymphoma with IRF4 rearrangement |
$20,575 | $48,008 | $32,005 | $12,574 |
| Non-Hodgkin lymphoma (NHL) | NHL – Lymphomatoid granulomatosis |
$20,657 | $48,200 | $32,134 | $12,624 |
| Non-Hodgkin lymphoma (NHL) | NHL – Lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia |
$20,740 | $48,393 | $32,262 | $12,674 |
| Non-Hodgkin lymphoma (NHL) | NHL – Mantle cell lymphoma | $20,823 | $48,587 | $32,391 | $12,725 |
| Non-Hodgkin lymphoma (NHL) | NHL – Monomorphic PTLD (B- and T-/NK-cell types) |
$20,906 | $48,781 | $32,521 | $12,776 |
| Non-Hodgkin lymphoma (NHL) | NHL – Monomorphic epitheliotropic intestinal T-cell lymphoma |
$20,990 | $48,976 | $32,651 | $12,827 |
| Non-Hodgkin lymphoma (NHL) | NHL – Mycosis fungoides | $21,074 | $49,172 | $32,781 | $12,878 |
| Non-Hodgkin lymphoma (NHL) | NHL – Nodal marginal zone B-cell lymphoma |
$21,158 | $49,369 | $32,912 | $12,930 |
| Non-Hodgkin lymphoma (NHL) | NHL – Nodal peripheral T-cell lymphoma with TFH phenotype |
$21,243 | $49,566 | $33,044 | $12,982 |
| Non-Hodgkin lymphoma (NHL) | NHL – Other B-cell lymphoma | $21,328 | $49,764 | $33,176 | $13,034 |
| Non-Hodgkin lymphoma (NHL) | NHL – Other T-cell/NK-cell lymphoma |
$21,413 | $49,964 | $33,309 | $13,086 |
| Non-Hodgkin lymphoma (NHL) | NHL – Peripheral T-cell lymphoma (PTCL), NOS |
$21,499 | $50,163 | $33,442 | $13,138 |
| Non-Hodgkin lymphoma (NHL) | NHL – Plasmablastic lymphoma |
$21,585 | $50,364 | $33,576 | $13,191 |
| Non-Hodgkin lymphoma (NHL) | NHL – Plasmacytic hyperplasia PTLD |
$21,671 | $50,565 | $33,710 | $13,243 |
| Non-Hodgkin lymphoma (NHL) | NHL – Polymorphic PTLD | $21,758 | $50,768 | $33,845 | $13,296 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary CNS lymphoma | $21,845 | $50,971 | $33,981 | $13,349 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous CD30+ T-cell lymphoproliferative disorders |
$21,932 | $51,175 | $34,116 | $13,403 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous CD4+ small / medium T-cell lymphoproliferative disorder |
$22,020 | $51,379 | $34,253 | $13,457 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma |
$22,108 | $51,585 | $34,390 | $13,510 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous DLBCL, leg type |
$22,196 | $51,791 | $34,527 | $13,564 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous follicle center lymphoma |
$22,285 | $51,998 | $34,666 | $13,619 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary cutaneous gamma-delta T-cell lymphoma |
$22,374 | $52,206 | $34,804 | $13,673 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary effusion lymphoma |
$22,464 | $52,415 | $34,943 | $13,728 |
| Non-Hodgkin lymphoma (NHL) | NHL – Primary mediastinal (thymic) large B-cell lymphoma |
$22,554 | $52,625 | $35,083 | $13,783 |
| Non-Hodgkin lymphoma (NHL) | NHL – Sézary syndrome | $22,644 | $52,835 | $35,224 | $13,838 |
| Non-Hodgkin lymphoma (NHL) | NHL – Splenic diffuse red pulp small B-cell lymphoma |
$22,734 | $53,047 | $35,364 | $13,893 |
| Non-Hodgkin lymphoma (NHL) | NHL – Splenic marginal zone B-cell lymphoma |
$22,825 | $53,259 | $35,506 | $13,949 |
| Non-Hodgkin lymphoma (NHL) | NHL – Subcutaneous panniculitis-like T-cell lymphoma |
$22,917 | $53,472 | $35,648 | $14,005 |
| Non-Hodgkin lymphoma (NHL) | NHL – Systemic EBV+ T-cell lymphoma of childhood |
$23,008 | $53,686 | $35,791 | $14,061 |
| Non-Hodgkin lymphoma (NHL) | NHL – T-cell / histiocytic rich large B-cell lymphoma |
$23,100 | $53,901 | $35,934 | $14,117 |
| Non-Hodgkin lymphoma (NHL) | NHL – T-cell large granular lymphocytic leukemia |
$23,193 | $54,116 | $36,077 | $14,173 |
| Non-Hodgkin lymphoma (NHL) | NHL – With features intermediate between DLBCL and classic Hodgkin Lymphoma |
$23,285 | $54,333 | $36,222 | $14,230 |
